|
HY-P1186-5mg
|
MedChemexpress LLC
|
Eledoisin Related Peptide [CAS 2990-43-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1490-1mg
|
MedChemexpress LLC
|
Bradykinin (2-9) [CAS 16875-11-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-P1490-10mg
|
MedChemexpress LLC
|
Bradykinin (2-9) [CAS 16875-11-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-P1490-5mg
|
MedChemexpress LLC
|
Bradykinin (2-9) [CAS 16875-11-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-P2148-1mg
|
MedChemexpress LLC
|
P-113 [CAS 190673-58-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-P2148-10mg
|
MedChemexpress LLC
|
P-113 [CAS 190673-58-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-P2148-5mg
|
MedChemexpress LLC
|
P-113 [CAS 190673-58-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-P3790-1mg
|
MedChemexpress LLC
|
T-F-Q-A-Y-P-L-R-E-A [CAS 117592-22-0]
|
|
|
|
|
HY-P99263-1mg
|
MedChemexpress LLC
|
Inclacumab [CAS 1256258-86-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P99263-10mg
|
MedChemexpress LLC
|
Inclacumab [CAS 1256258-86-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P99263-5mg
|
MedChemexpress LLC
|
Inclacumab [CAS 1256258-86-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-16707-1mL
|
MedChemexpress LLC
|
CH 5450 [CAS 252557-97-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1490-1mL
|
MedChemexpress LLC
|
Bradykinin (2-9) [CAS 16875-11-9] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-146127A-1mg
|
MedChemexpress LLC
|
Grb2 SH2 domain inhibitor 1 (TFA)
|
|
|
|
|
HY-146127A-10mg
|
MedChemexpress LLC
|
Grb2 SH2 domain inhibitor 1 (TFA)
|
|
|
|
|
HY-146127A-5mg
|
MedChemexpress LLC
|
Grb2 SH2 domain inhibitor 1 (TFA)
|
|
|
|
|
HY-P0325-1mg
|
MedChemexpress LLC
|
V5 Epitope Tag Peptide (TFA)
|
|
|
|
|
HY-P0325-10mg
|
MedChemexpress LLC
|
V5 Epitope Tag Peptide (TFA)
|
|
|
|
|
HY-P0325-5mg
|
MedChemexpress LLC
|
V5 Epitope Tag Peptide (TFA)
|
|
|
|
|
HY-P1159A-10mg
|
MedChemexpress LLC
|
[D-p-Cl-Phe6,Leu17]-VIP (TFA)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1159A-5mg
|
MedChemexpress LLC
|
[D-p-Cl-Phe6,Leu17]-VIP (TFA)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1376A-1mg
|
MedChemexpress LLC
|
G-Protein antagonist peptide (TFA)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1376A-10mg
|
MedChemexpress LLC
|
G-Protein antagonist peptide (TFA)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1376A-5mg
|
MedChemexpress LLC
|
G-Protein antagonist peptide (TFA)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1674A-10mg
|
MedChemexpress LLC
|
Mu repavadin (TFA)
|
|
COVID-19-immunoregulation
|
|
